UltraTech Cement Limited vs Ultramarine & Pigments Ltd

A side-by-side comparison of UltraTech Cement Limited (ULTRACEMCO) and Ultramarine & Pigments Ltd (ULTRMARINE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, UltraTech Cement Limited leads ULTRACEMCO vs ULTRMARINE on 8 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth· not comparable—
  • Size & financial health31

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

39.29
P/E ratio
0.00
4.25
P/B ratio
0.00
2.19%
Dividend yield
0.00%
₹277.62
EPS
₹25.70

Profitability

ULTRACEMCO takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

10.66%
Return on equity
7.99%
12.88%
Return on capital
10.00%
19.23%
EBITDA margin
17.00%
9.25%
Net margin
10.79%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

11.86%
Revenue CAGR (3Y) even
—
17.30%
Profit CAGR (3Y) even
—

Size & financial health

ULTRACEMCO takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹3.22L Cr
Market cap
₹0 Cr
₹88,512 Cr
Revenue
₹695 Cr
₹8,188 Cr
Net profit
₹75 Cr
0.30
Debt / equity
0.00
UltraTech Cement Limited
  • + ["Company has been maintaining a healthy dividend payout of 86.4%"]
  • − []
Ultramarine & Pigments Ltd
  • + ["Company is almost debt free.", "Stock is trading at 1.15 times its book value", "Company has been maintaining a healthy dividend payout of 23.3%"]
  • − ["Company has a low return on equity of 7.89% over last 3 years."]
UltraTech Cement Limited full analysis Ultramarine & Pigments Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ULTRACEMCO vs ULTRMARINE: Share Price, Valuation & Which to Buy | DocStoX